Power Law company profile

Ypsomed

Health Tech & Medtech · Bern, Switzerland · Founded 2003 · IPO 2004 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$3.65B

Market cap · Apr/2026

Revenue

$686M

Latest reported FY

Global footprint

Where Ypsomed has talent and traffic

AI talent share

0.1% of workforce is AI talent
(2 of 1,357 staff)

Core AI00%

Other AI20.15%

Non-AI workforce1,35599.85%

Patent intelligence

$92M patent portfolio · 189 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$92M

2.5% of market cap · 5.5× smaller than top peer Insulet ($502M)

189 active patent families

Where Ypsomed innovates Biomedical engineeringInjection devicePharmaceutical drugMechanical engineeringPhysics

Below peer median on Legal

Quality vs same-sector peers

Ypsomed on the five Patsnap quality dimensions

Ypsomed in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Ypsomed concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Ypsomed and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Ypsomed on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo